Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 分子標的
  6. Gabaergicシグナル伝達は,腫瘍細胞の侵入と,大腸がんにおける全生存率の低下に貢献する.
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 分子標的
  6. Gabaergicシグナル伝達は,腫瘍細胞の侵入と,大腸がんにおける全生存率の低下に貢献する.

関連する実験動画

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K

GABAergicシグナル伝達は,腫瘍細胞の侵入と,大腸がんにおける全生存率の低下に貢献する.

Carly Strelez1, Francesca Battaglin2, Rachel Perez1

  • 1Ellison Medical Institute, Los Angeles, CA, USA.

Oncogene
|August 24, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

ガンマアミノバター酸 (GABA) 経路遺伝子GAD1の高い発現は,転移性大腸がん (CRC) の悪化と関連しています. この神経伝達物質は,特にラス変異性腫瘍の侵入性に影響します.

さらに関連する動画

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.1K

関連する実験動画

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.6K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.6K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.1K

科学分野:

  • 腫瘍学
  • 神経科学
  • 分子生物学

背景:

  • ガンマアミノバター酸 (GABA) を含む神経伝達物質の信号伝達経路は,がんの進行に影響を与える可能性があります.
  • 以前の研究では,神経伝達物質と結腸直腸がん (CRC) の発症と転移の間の潜在的な関連が示唆されています.

研究 の 目的:

  • 転移性大腸がん (CRC) の GABAergicシグナル伝達の役割を調査する.
  • GABA経路の遺伝子発現とCRCにおける患者の生存結果との関連を決定する.

主な方法:

  • 遺伝子発現と生存を相関させるIII相試験 (CALGB/SWOG 80405) の臨床データの分析
  • 癌細胞ラインの転移図 (MetMap) と機能研究のための腫瘍オンチップモデルを使用した.
  • GAD1のノックダウン,薬学的抑制,および外因的なGABAの腫瘍侵入に対する効果を調査した.
  • ラス変異性CRCのアウトカムについて,公開されているデータを分析した.

主要な成果:

  • 転移性CRC患者における高GAD1発現と低ABAT発現は,より悪化した全生存と進行性のない生存と相関していた.
  • 高GAD1発現は,がん細胞系における転移の可能性の増加と関連していた.
  • GAD1の抑制は腫瘍の侵入を減らし,GABAはそれを促進した.
  • 腫瘍由来GABAとGAD1の発現の上昇は,Ras変異/変異性腫瘍で観察され,悪質なアウトカムに関連した.
  • 結論:

    • 特にGAD1によるGABAシグナリングは,大腸がん (CRC) の侵入性において重要な役割を果たします.
    • これらの発見は,Ras変異のCRCにおける神経伝達物質の信号伝達の影響を強調し,GAD1を潜在的な治療標的として示唆しています.
    • この研究は,新しい発見を促す臨床データの価値と,高度な臨床前モデルの必要性を強調しています.